SMHSMH·1hBusiness
score-0.85
Aussie Pharma Giant Faces $88b Reckoning Beyond Trump Tariffs, Prompting Strategic Overhaul
Original
$88b bloodbath shows Trump is not the only problem for Aussie pharma giant
“Catastrophic language ('bloodbath,' 'disaster of historic proportions') creates alarm about financial loss without context or recovery pathways.”